Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acasti Pharma Inc.

    NASDAQ: ACST · Real-Time Price · USD
    3.37
    0.13 (4.01%)
    At close: Oct 25, 2024, 8:00 PM

    Acasti Pharma Statistics

    Share Statistics

    Acasti Pharma has 10.14M shares outstanding. The number of shares has increased by 7.88% in one year.

    Shares Outstanding

    n/a
    		 10.14M

    Shares Change (YoY)

    n/a
    		 7.88%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 5,553

    FTD / Avg. Volume

    n/a
    		 16.7%

    Short Selling Information

    The latest short interest is 154.19K, so 1.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 154.19K

    Short % of Shares Out

    n/a
    		 1.52%

    Short % of Float

    n/a
    		 1.93%

    Short Ratio (days to cover)

    n/a
    		 7.75

    Valuation Ratios

    The PE ratio is -2.56 and the forward PE ratio is null. Acasti Pharma's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -2.56

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.53

    P/FCF Ratio

    n/a
    		 -2.66

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Acasti Pharma has an Enterprise Value (EV) of 9.87M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.87

    EV / EBIT

    n/a
    		 -0.8

    EV / FCF

    n/a
    		 -0.8

    Financial Position

    The company has a current ratio of 14.26, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 14.26

    Quick Ratio

    n/a
    		 14.26

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -12.42

    Financial Efficiency

    Return on Equity is -20.82% and Return on Invested Capital is -16.1%.

    Return on Equity

    n/a
    		 -20.82%

    Return on Assets

    n/a
    		 -17.53%

    Return on Invested Capital

    n/a
    		 -16.1%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-401,656.25

    Employee Count

    n/a
    		 32

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.78M

    Effective Tax Rate

    n/a
    		 12.15%

    Stock Price Statistics

    The stock price has increased by 16.21% in the last 52 weeks. The beta is 1.52, so Acasti Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.52

    52-Week Price Change

    n/a
    		 16.21%

    50-Day Moving Average

    n/a
    		 3.11

    200-Day Moving Average

    n/a
    		 2.99

    Relative Strength Index (RSI)

    n/a
    		 54.72

    Average Volume (20 Days)

    n/a
    		 33,247

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -11K

    Operating Income

    n/a
    		 -11.31M

    Net Income

    n/a
    		 -12.85M

    EBITDA

    n/a
    		 -11.3M

    EBIT

    n/a
    		 -17.68M

    Earnings Per Share (EPS)

    n/a
    		 -1.35
    Full Income Statement

    Balance Sheet

    The company has 23M in cash and 0 in debt, giving a net cash position of 23M.

    Cash & Cash Equivalents

    n/a
    		 23M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -211.12M

    Total Assets

    n/a
    		 69.72M

    Working Capital

    n/a
    		 17.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.33M and capital expenditures -22K, giving a free cash flow of -12.36M.

    Operating Cash Flow

    n/a
    		 -12.33M

    Capital Expenditures

    n/a
    		 -22K

    Free Cash Flow

    n/a
    		 -12.36M

    FCF Per Share

    n/a
    		 -1.3
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ACST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -39.1%

    FCF Yield

    n/a
    		 -37.58%
    Dividend Details

    Analyst Forecast

    The average price target for ACST is $10, which is 196.7% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 196.7%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 10, 2023. It was a backward split with a ratio of 1:6.

    Last Split Date

    n/a
    		 Jul 10, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:6

    Scores

    Altman Z-Score

    n/a
    		 -2.64

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist